Manish J Gandhi (Manish Gandhi)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 6

Top Topics

High Throughput

Patient Reported Outcomes

Liquid Chromatography

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Justin E Juskewitch, Micah D Zuccarelli, Kristie K Clymer, Laurie L Wakefield, Justin D Kreuter, Manish J Gandhi
Prozone rates in the solid-phase platelet crossmatch assay and correlation with class I HLA antibody levels. Transfusion 61 (11) (2021)
Justin E Juskewitch, Micah D Zuccarelli, Holly E Berg, Daniel D Summerfield, Laurie L Wakefield, Manish J Gandhi
Transfusion medicine illustrated: When less is more for HLA antibodies. Transfusion 61 (1) (2020)
Justin E Juskewitch, Manish J Gandhi, Justin D Kreuter, Andrew P Norgan
Development and performance characteristics of Platelet Virtual Crossmatch (PLT VXM), a software application for the evaluation and management of platelet transfusion-refractory patients. Transfusion 60 (10) (2020)
Rachel K Horton, Micah D Zuccarelli, Laurie L Wakefield, Margaret A DiGuardo, Manish J Gandhi, Justin E Juskewitch
False-negative solid-phase platelet crossmatch results due to prozone phenomenon. Transfusion 60 (12) (2020)
Nisar A Baig, Brian A Dukek, Deborah K Falbo, Laurie L Wakefield, Margaret A DiGuardo, Aleh Bobr, Justin D Kreuter, Manish J Gandhi
Daratumumab interference in flow cytometric anti-granulocyte antibody testing can be overcome using non-human blocking antibodies. Vox sanguinis 116 (1) (2020)
Gizem Tumer, Thomas Gniadek, Jennifer Baye, Ryan Pena, Paul Warner, Mark Fung, Lynette Beaudin, Heather Dunckley, Manish J Gandhi, Birgit Gathof, Susan Hsu, Ellen Klohe, Nalaja Marcus, Roberta Bamert, Shona Sims, Minoko Takanashi, Silvano Wendel, Claudia S Cohn, null null
The effect of serum pretreatment regimens for the detection of HLA class I antibodies in platelet-refractory patients. Transfusion 60 (3) (2020)